EDESA BIOTECH, INC.: 10-Q filed 2015-02-09
What EDESA BIOTECH, INC. reported in its quarterly report filed 2015-02-09 (fiscal Q1 2015): 31 published measures, 97 facts as tagged in accession 0001144204-15-007126.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-02-09
- Fiscal period
- fiscal Q1 2015
- Accession
- 0001144204-15-007126 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All EDESA BIOTECH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 13,425,793 | USD | |
| At 2014-09-30 | 14,827,715 | USD | |
| At 2014-08-31 | 14,473,962 | USD | |
| At 2013-09-30 | 16,071,983 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 4,188,951 | USD | |
| At 2014-09-30 | 4,362,980 | USD | |
| At 2014-08-31 | 6,773,329 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 9,236,842 | USD | |
| At 2014-09-30 | 10,464,735 | USD | |
| At 2014-08-31 | 7,700,633 | USD | |
| At 2013-09-30 | 6,536,786 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 12,763,533 | USD | |
| At 2014-09-30 | 13,769,953 | USD | |
| At 2014-08-31 | 13,427,404 | USD | |
| At 2013-12-31 | 16,725,570 | USD | |
| At 2013-09-30 | 15,478,038 | USD | |
| At 2013-08-31 | 7,859,889 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -1,343,477 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 1,127,904 | USD | 30 |
| 2013-10-01 to 2013-12-31 | -5,577,190 | USD | 92 |
| 2013-09-01 to 2013-09-30 | -240,389 | USD | 30 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 38,849 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 13,477 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 209,129 | USD | 92 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 212,661 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 52,786 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 58,825 | USD | 92 |
| 2013-09-01 to 2013-09-30 | 13,839 | USD | 30 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | -33,835,763 | USD | |
| At 2014-09-30 | -32,492,286 | USD | |
| At 2014-08-31 | -33,620,190 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 79,461,013 | shares | 92 |
| 2014-09-01 to 2014-09-30 | 78,675,750 | shares | 30 |
| 2013-10-01 to 2013-12-31 | 73,978,736 | shares | 92 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 79,461,013 | shares | 92 |
| 2014-09-01 to 2014-09-30 | 87,140,449 | shares | 30 |
| 2013-10-01 to 2013-12-31 | 73,978,736 | shares | 92 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -0.02 | USD/shares | 92 |
| 2014-09-01 to 2014-09-30 | 0.01 | USD/shares | 30 |
| 2013-10-01 to 2013-12-31 | -0.08 | USD/shares | 92 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -0.02 | USD/shares | 92 |
| 2014-09-01 to 2014-09-30 | 0.01 | USD/shares | 30 |
| 2013-10-01 to 2013-12-31 | -0.08 | USD/shares | 92 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 9,800 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 3,800 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 800 | USD | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 389,654 | USD | |
| At 2014-09-30 | 388,340 | USD | |
| At 2014-08-31 | 387,392 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 86,865 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 36,509 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 468,717 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 13,020,239 | USD | |
| At 2014-09-30 | 14,423,475 | USD | |
| At 2014-08-31 | 14,070,670 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 3,955,344 | USD | |
| At 2014-09-30 | 672,174 | USD | |
| At 2014-08-31 | 1,420,666 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 1,538,075 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 505,109 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 1,754,432 | USD | 92 |
| 2013-09-01 to 2013-09-30 | 351,189 | USD | 30 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 134,308 | USD | |
| At 2014-09-30 | 34,891 | USD |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-09-30 | 34,930 | USD | 30 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 418,821 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 178,280 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 548,225 | USD | 92 |
| 2013-09-01 to 2013-09-30 | 203,367 | USD | 30 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 79,546,650 | shares | |
| At 2014-09-30 | 79,419,850 | shares | |
| At 2014-08-31 | 78,268,850 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 945,452 | USD | |
| At 2014-09-30 | 906,603 | USD | |
| At 2014-08-31 | 893,126 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-12-31 | 555,798 | USD | |
| At 2014-09-30 | 518,263 | USD | |
| At 2014-08-31 | 505,734 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 942,153 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 293,130 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 1,021,130 | USD | 92 |
| 2013-09-01 to 2013-09-30 | 112,892 | USD | 30 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 37,535 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 12,529 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 31,811 | USD | 92 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-09-01 to 2013-09-30 | 386 | USD | 30 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -8,263 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 1,584,027 | USD | 30 |
| 2013-10-01 to 2013-12-31 | -3,880,783 | USD | 92 |
Income taxes paid, net
Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 9,800 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 800 | USD | 30 |
| 2013-10-01 to 2013-12-31 | 800 | USD | 92 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | -8,045 | USD | 92 |
| 2014-09-01 to 2014-09-30 | -12,352 | USD | 30 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2014-12-31 | 99,417 | USD | 92 |
| 2014-09-01 to 2014-09-30 | 34,891 | USD | 30 |
| 2013-10-01 to 2013-12-31 | -158,284 | USD | 92 |
Inspect the source
- Entity
- EDESA BIOTECH, INC. / CIK 0001540159
- Captured
- 2026-09-20T09:17:32.413Z
- SEC response SHA-256
0f44de1ccf1eff46a1af17dc21d4a3bb38216bbf46e813f5a136d29e08bfd65d
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001540159.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))